Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It is not an FDA-approved drug or medical device
The incidence of TC is the ninth highest in the world (Palanca et al., 2022
The initial consultation is $99
Patients with pre-existing diabetic retinopathy should monitor for vision changes during this period of rapid glycemic improvement
You deserve to feel confident and in control again
Conducting clinical trials that demonstrate the clinical advantage of the new delivery system reduced dosing frequency, improved tolerability, better patient adherence sufficient to support physician and payer acceptance of the price premium
US$ 20.58
US$ 21.07
US$ 29.04
US$ 26.07
US$ 27.92
US$ 27.27
US$ 24.75
US$ 21.80
US$ 24.62
US$ 22.13
US$ 22.03
